Literature DB >> 21290272

[Quality assurance and quality management in medical rehabilitation].

E Farin1, W H Jäckel.   

Abstract

External quality assurance in medical rehabilitation is characterized by the programs of Germany's two largest providers of rehabilitation (the German pension insurance and the statutory health insurance). The programs were developed with considerable input from scientific institutes. Their strengths lie in measuring several relevant dimensions of quality, the comprehensive implementation for nearly all illnesses treated, integration of the patient perspective, and realization of prospective study designs with follow-up. Weaknesses include low relevance for patient allocation and compensation, the absence of systematic evaluations, and a lack of published patient information on the results of the quality measurements. Internal quality management in medical rehabilitation is regulated by sweeping legal guidelines. Since 2009, a statutory agreement has been in effect which includes a provision that all inpatient rehabilitation centers must be certified by October 2012. Areas for potential improvements in internal quality management processes include an improved theoretical basis, higher specificity for rehabilitation, and a more transparent, methodically improved structure of certification procedures.

Entities:  

Mesh:

Year:  2011        PMID: 21290272     DOI: 10.1007/s00103-010-1206-9

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  1 in total

1.  Influence of quality of care and individual patient characteristics on quality of life and return to work in survivors of the acute respiratory distress syndrome: protocol for a prospective, observational, multi-centre patient cohort study (DACAPO).

Authors:  Susanne Brandstetter; Frank Dodoo-Schittko; Sebastian Blecha; Philipp Sebök; Kathrin Thomann-Hackner; Michael Quintel; Steffen Weber-Carstens; Thomas Bein; Christian Apfelbacher
Journal:  BMC Health Serv Res       Date:  2015-12-17       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.